Wegovy® and the Ivim weight loss program

When combined with a reduced calorie diet and increased physical activity, Wegovy®, a weekly semaglutide injection, can help you lose weight, curb hunger, and regulate blood sugar.*

*Disclaimer: Wegovy® may be prescribed by an Ivím provider if deemed appropriate for your medical needs. For additional safety information, please see our Safety Page.

Wegovy® (semaglutide) injection is a glucagon-like peptide-1 (GLP-1) receptor agonist originally approved for the treatment of type 2 diabetes. It functions by mimicking a hormone that targets areas of the brain involved in appetite regulation.

Wegovy® works by slowing gastric emptying, enhancing feelings of fullness, and suppressing appetite, which can help manage weight when combined with diet and exercise.

Coverage depends on your insurance plan and whether Wegovy® is prescribed for an FDA-approved use. Ivím Health offers a free initial consultation to navigate insurance or explore self-pay options.

Wegovy® is FDA approved for some adults who are overweight with other weight-related medical problems, to help them lose excess body weight and keep the weight off. You may be prescribed Wegovy® online by an Ivím Health provider as part of your weight management program.

Choosing a GLP-1 medication like Wegovy® depends on individual health history and insurance coverage. Your Ivím provider can help determine which GLP-1 is best for weight loss on your journey.

*Disclaimer: Wegovy® is a registered trademark of Novo Nordisk. Ivím is not affiliated with Novo Nordisk.